Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001649094-24-000075
Filing Date
2024-10-03
Accepted
2024-10-03 16:15:39
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1727986533.html 4  
1 FORM 4 wk-form4_1727986533.xml 4 11300
  Complete submission text file 0001649094-24-000075.txt   12856
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300 SAN CARLOS CA 94070
Business Address
Eydelman Mikhail (Reporting) CIK: 0001918033 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 241351693